Skip to content

Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 '22

By: Newsfile

Dallas, Texas--(Newsfile Corp. - April 10, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): The full report can be accessed by clicking on the following link: https://stonegateinc.com/reports/BPTH_Q422.pdf

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

  • Owning the Breakthrough Technology
  • Ongoing Clinical Trials
  • First Patients Recently Dosed

Cannot view this image? Visit: https://images.newsfilecorp.com/files/7294/161882_figure1_550.jpg

Click image above to view full announcement.


About Stonegate Capital Partners
Stonegate Capital Partners is a Dallas-based corporate advisory firm dedicated to serving the specialized needs of small-cap public companies. Since our inception, our mission has been to find innovative, undervalued public companies for our network of leading institutional investors who seek high-quality investment opportunities.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/161882

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.55
+5.86 (2.66%)
AAPL  273.68
+2.19 (0.81%)
AMD  212.28
+8.50 (4.17%)
BAC  51.99
+0.43 (0.83%)
GOOG  316.57
+16.93 (5.65%)
META  609.47
+15.22 (2.56%)
MSFT  472.44
+0.31 (0.07%)
NVDA  178.70
-0.18 (-0.10%)
ORCL  202.19
+3.43 (1.73%)
TSLA  415.89
+24.80 (6.34%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.